A
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Abraham Reddy's research focuses on the analysis of health data to understand disease patterns and treatment outcomes. His work includes epidemiological studies on infectious diseases such as Leptospirosis and SARS-CoV-2, investigating risk factors for severe outcomes in specific populations like those with Type 2 Diabetes Mellitus.
Reddy also investigates patterns of medication use and persistence for cardioprotective anti-hyperglycemic agents in the United States. His publications explore statistical modeling for disease forecasting and vulnerability mapping, as well as clinical outcomes associated with specific medical interventions. His research network includes collaborators from the University of Arkansas for Medical Sciences.
Metrics
- h-index: 5
- Publications: 14
- Citations: 322
Selected Publications
-
Clinical Improvements Following Posterior Cranial Vault Remodeling in a Patient with Bronchopulmonary Dysplasia: A Case Report (2025)
Collaboration Network
Top Collaborators
Callahan Clark
6 shared publications
- Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States
- Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States
- Patterns of Medication Use and Prescription Fills for Cardioprotective Anti-Hyperglycemic Agents in the United States
- U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS
- Specialty Visits and Real-world Initiation of Cardioprotective Anti-hyperglycemic Medications Among US Adults with Type 2 Diabetes
Showing 5 of 6 shared publications
Arash Aghajani Nargesi
University of New Haven (US)
5 shared publications
- Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States
- Patterns of Medication Use and Prescription Fills for Cardioprotective Anti-Hyperglycemic Agents in the United States
- U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS
- Specialty Visits and Real-world Initiation of Cardioprotective Anti-hyperglycemic Medications Among US Adults with Type 2 Diabetes
- Abstract 10019: Access to Specialty Cardiovascular Care and Uptake of Cardioprotective Anti-Hyperglycemic Agents Among Adults With Type 2 Diabetes: A Cohort Study
Rohan Khera
Yale University (US)
5 shared publications
- Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States
- Patterns of Medication Use and Prescription Fills for Cardioprotective Anti-Hyperglycemic Agents in the United States
- U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS
- Specialty Visits and Real-world Initiation of Cardioprotective Anti-hyperglycemic Medications Among US Adults with Type 2 Diabetes
- Abstract 10019: Access to Specialty Cardiovascular Care and Uptake of Cardioprotective Anti-Hyperglycemic Agents Among Adults With Type 2 Diabetes: A Cohort Study
Samuel Amodeo
Optum (United States) (US)
4 shared publications
- Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States
- Patterns of Medication Use and Prescription Fills for Cardioprotective Anti-Hyperglycemic Agents in the United States
- U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS
- Specialty Visits and Real-world Initiation of Cardioprotective Anti-hyperglycemic Medications Among US Adults with Type 2 Diabetes
Lian Chen
Yale New Haven Hospital (US)
3 shared publications
- Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States
- Patterns of Medication Use and Prescription Fills for Cardioprotective Anti-Hyperglycemic Agents in the United States
- U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS
Mengni Liu
Elmhurst College (US)
3 shared publications
- Patterns of Medication Use and Prescription Fills for Cardioprotective Anti-Hyperglycemic Agents in the United States
- Specialty Visits and Real-world Initiation of Cardioprotective Anti-hyperglycemic Medications Among US Adults with Type 2 Diabetes
- Abstract 10019: Access to Specialty Cardiovascular Care and Uptake of Cardioprotective Anti-Hyperglycemic Agents Among Adults With Type 2 Diabetes: A Cohort Study
Evangelos K. Oikonomou
3 shared publications
- Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States
- Patterns of Medication Use and Prescription Fills for Cardioprotective Anti-Hyperglycemic Agents in the United States
- U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS
Marc A. Suchard
Fielding Graduate University (US)
3 shared publications
- Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States
- Patterns of Medication Use and Prescription Fills for Cardioprotective Anti-Hyperglycemic Agents in the United States
- U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS
Darren K. McGuire
Parkland Health & Hospital System (US)
3 shared publications
- Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States
- Patterns of Medication Use and Prescription Fills for Cardioprotective Anti-Hyperglycemic Agents in the United States
- U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS
Zhenqiu Lin
Yale New Haven Hospital (US)
3 shared publications
- Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States
- Patterns of Medication Use and Prescription Fills for Cardioprotective Anti-Hyperglycemic Agents in the United States
- U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS
Silvio E. Inzucchi
Yale University (US)
3 shared publications
- Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States
- Patterns of Medication Use and Prescription Fills for Cardioprotective Anti-Hyperglycemic Agents in the United States
- U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS
Mengni Liu
Yale New Haven Hospital (US)
2 shared publications
- Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United States
- U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS
Matteo Convertino
Tsinghua University (CN)
1 shared publication
- Eco-epidemiological scaling of Leptospirosis: Vulnerability mapping and early warning forecasts
Yang Liu
London School of Hygiene & Tropical Medicine (GB)
1 shared publication
- Eco-epidemiological scaling of Leptospirosis: Vulnerability mapping and early warning forecasts
Claudia Muñoz‐Zanzi
University of Minnesota (US)
1 shared publication
- Eco-epidemiological scaling of Leptospirosis: Vulnerability mapping and early warning forecasts
Similar Researchers
Based on overlapping research topics
Keyur S. Vyas
University of Arkansas for Medical Sciences
COVID-19 epidemiological studies
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Wilton Remigio
Arkansas State University
COVID-19 epidemiological studies
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Maxwell Taylor
University of Arkansas for Medical Sciences
COVID-19 epidemiological studies
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Sandra Johnson
University of Arkansas – Fort Smith
COVID-19 epidemiological studies
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Donald B. McCormick
University of Arkansas for Medical Sciences
COVID-19 epidemiological studies
SARS-CoV-2 and COVID-19 Research
Cardiovascular Function and Risk Factors
Katie Loethen
University of Arkansas at Fayetteville
COVID-19 epidemiological studies
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research